FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/11/047307 [Registered on: 15/11/2022] Trial Registered Prospectively
Last Modified On: 31/08/2023
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Guided meditation]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effects of guided meditation in critically ill patients 
Scientific Title of Study   Physiological and Psychological effects of guided meditation in critically ill patients  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Bhalendu Vaishnav 
Designation  Professor and Head, Department of Medicine 
Affiliation  Pramukhswami Medical College 
Address  Intensive care unit, Department of Medicine Pramukhswami Medical College, Bhaikaka University, Karamsad

Anand
GUJARAT
388325
India 
Phone  9825717481  
Fax    
Email  bhalendusv@charutarhealth.org  
 
Details of Contact Person
Scientific Query
 
Name  Dr Bhalendu Vaishnav 
Designation  Professor and Head, Department of Medicine 
Affiliation  Pramukhswami Medical College 
Address  Intensive care unit, Department of Medicine Pramukhswami Medical College, Bhaikaka University, Karamsad

Anand
GUJARAT
388325
India 
Phone  9825717481  
Fax    
Email  bhalendusv@charutarhealth.org  
 
Details of Contact Person
Public Query
 
Name  Dr Bhalendu Vaishnav 
Designation  Professor and Head, Department of Medicine 
Affiliation  Pramukhswami Medical College 
Address  Intensive care unit, Department of Medicine Pramukhswami Medical College, Bhaikaka University, Karamsad.

Anand
GUJARAT
388325
India 
Phone  9825717481  
Fax    
Email  bhalendusv@charutarhealth.org  
 
Source of Monetary or Material Support  
Institution, Principal Investigator. Dr Bhalendu Vaishnav. Intensive care unit, Department of Medicine Pramukhswami Medical College, Bhaikaka University, Karamsad 388325 
 
Primary Sponsor  
Name  Dr Bhalendu Vaishnav  
Address  Professor and Head, Department of Medicine Pramukhswami Medical College, Karamsad 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Bhalendu Vaishnav  Shree Krishna Hospital  Intensive care unit, Shree Krishna Hospital, Pramukhswami Medical College, KaramsadKaramsad
Anand
GUJARAT 
9825717481

bhalendusv@charutarhealth.org 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee 2  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O94||Sequelae of complication of pregnancy, childbirth, and the puerperium, (2) ICD-10 Condition: S069||Unspecified intracranial injury,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Guided meditation  Structured guided meditation practice will be offered to the participants through an audio device for duration of 20 minutes daily for at least 3 days. 
Comparator Agent  Standard Care  Control arm will receive treatment as per standard of care 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Subset 1__ Physiological and Psychological effects of guided meditation in critically ill obstetric patients_Inclusion Criteria_Critically ill conscious obstetric patients (antenatal/postnatal) who are not on mechanical ventilation.
Subset 2_Physiological and Psychological effects of guided meditation in critically ill traumatic brain injury patients who are on mechanical ventilation.Inclusion Criteria_Critically ill traumatic brain injury patients (on medical management/ post operative patients) who are on mechanical ventilation

 
 
ExclusionCriteria 
Details  Subset 1_Exclusion Criteria
1. Hemodynamically unstable patients.
2. Patients having any psychiatric disease
3. Patients whose condition gets changed to other category due to course of illness (e.g. those who worsen and require ventilation, etc)
4. Patients with altered mental status.
5. Patients having cardiac arrythmias.
6. Patients would be excluded from the experiment in the event of death, transferring to other medical centers or discharge, the need for emergency surgery during the study.
Subset_2:1. Hemodynamically unstable patients.
2. Patients on N-M blockage drugs
3. Patients having any psychiatric disease
4. Likely survival of less than 3 days
5. Patients whose condition gets changed to other category due to course of illness (e.g. those who improved and extubated, etc)
6. Patients would be excluded from the experiment in the event of death, transferring to other medical centers or discharge, the need for emergency surgery during the study.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Subset 1 & 2:Effect of guided meditation on heart rate variability  Before and after each guided meditation session on all 3 days 
 
Secondary Outcome  
Outcome  TimePoints 
Subset_1_Effect of guided meditation on anxiety and wellbeing as measured by visual analogue scale, Effect of guided meditation on physiological parameters, viz. Heart rate, Blood pressure, SpO2, Respiratory rate
Subset_2_Effect of guided meditation on sedative requirement,effect of guided meditation on opioid requirement,Effect of guided meditation on physiological parameters, viz., Heart rate, Blood pressure, SpO2, Respiratory rate.


 
Before and after each guided meditation session on all 3 days 
 
Target Sample Size   Total Sample Size="200"
Sample Size from India="200" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   17/11/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details
Modification(s)  
Results will be published apprpriately 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [bhalendusv@charutarhealth.org].

  6. For how long will this data be available start date provided 30-06-2024 and end date provided 31-12-2027?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary
Modification(s)  

Critically ill patients undergo a significant amount of environmental and psycho-physical stress. Indeed, not only is their severe and debilitating underlying clinical condition stressful, but they also are subject to a wide array of stressors, related to the environment in which they are cared and to the procedures to which they undergo, which all have been associated with significant discomfort. Anxiety is a common finding in hospitalized patients, and even more in those who are critically ill. It was suggested that up to 80% of patients in the ICU may suffer from anxiety, especially in those undergoing mechanical ventilation.

The categories of long-term effects of sepsis include immune-metabolic, neurocognitive, psychiatric, and physical derangements. These effects lead to increased mortality and severely worsened health-related quality of life. Health care professionals and family members pay a heavy cost—in both money and energy—in caring for these patients with sizable health issues. The current goals of care for patients who survive sepsis include approaches that are effective in early sepsis, controlling pain, agitation, and delirium, and early mobilization. However, there is an unmet need of developing efficient therapeutic strategies specifically tailored towards sepsis survivors. While the administration of drugs plays an undoubtful role in the management of ICU-related stress, there are a variety of non-pharmacologic interventions and protocols, that have shown to be able to effectively prevent and treat various manifestations of ICU stay. 

Various relaxation interventions have been shown to reduce stress, anxiety and pain level, bring about parasympathetic shift in heart rate variability and promoting relaxation in different cohorts of healthy individuals and those suffering from various diseases. However, there is dearth of studies in this area.

Present study aims to analyze physiological and psychological  effects of guided meditation on critically ill patients::Subset 1: Conscious, critically ill obstetric  patients, Subset 2: Unconscious patients of Traumatic brain Injury

 
Close